VKC patients (n = 22) Healthy controls (n = 20)
Age (years) Age (years) Age (years)
Mean (range) 10 (5 – 17) 10 (5 – 15)
Median 9 9
Male / Female 16 / 6 13 / 7
VKC type (%) VKC type (%) VKC type (%)
Tarsal 6 (27%)
Limbal 5 (23%)
Mixed 11 (50%)
IgE sensitization (%) IgE sensitization (%) IgE sensitization (%)
Present 10 (45%)
Absent 12 (55%) 20 (100%)
Topical treatment (%) Topical treatment (%) Topical treatment (%)
CsA 2 (9%)
Antihistamine ± Mast cell stabilizer 11 (50%)
None 9 (41%) 20 (100%)